Results 71 to 80 of about 264,442 (390)

Clinical characteristics and outcomes of heart failure with preserved, mildly reduced, and reduced ejection fraction: A 6-month follow-up study

Medical Journal of Babylon, 2022
Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman, Abdulkareem Abdulwahab Al-Othman   +1 more
doaj   +1 more source

Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure [PDF]

, 2019
Sympathetic nervous system hyperactivity has a well-recognized role in the pathophysiology of heart failure with reduced left ventricular ejection fraction.
Bonaduce, Domenico, Bosso, Giorgio, Campi, Giacomo, Cuocolo, Alberto, Hassoun, Paul, Mercurio, Valentina, Parrella, Paolo, Pellegrino, Teresa, Petretta, Mario, Piscopo, Valentina, Tocchetti, Carlo Gabriele   +10 more
core   +1 more source

Effect of allogeneic adipose tissue‐derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction – the SCIENCE trial

European Journal of Heart Failure, 2023
The aim of the SCIENCE trial was to investigate whether a single treatment with direct intramyocardial injections of adipose tissue‐derived mesenchymal stromal cells (CSCC_ASCs) was safe and improved cardiac function in patients with chronic ischaemic ...
A. Qayyum, B. V. van Klarenbosch, S. Frljak, A. Cerar, G. Poglajen, D. Traxler-Weidenauer, Paweł Nadrowski, Christina Paitazoglou, B. Vrtovec, M. Bergmann, S. Chamuleau, W. Wojakowski, M. Gyöngyösi, A. Kraaijeveld, Kristian Schultz Hansen, Karsten Vrangbaek, E. Jørgensen, S. Helqvist, F. Joshi, E. M. Johansen, B. Follin, Morten Juhl, L. D. Højgaard, A. B. Mathiasen, A. Ekblond, M. Haack-Sørensen, J. Kastrup   +26 more
semanticscholar   +1 more source

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial

ESC Heart Failure, 2022
Aims Treatment response to vericiguat, based on baseline N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) subgroups specified in the protocol, was evaluated in the heart failure (HF) VICTORIA trial population by post hoc analysis of combined lower ...
Michele Senni, Jose Lopez‐Sendon, Alain Cohen‐Solal, Piotr Ponikowski, Richard Nkulikiyinka, Cecilia Freitas, Vanja Miodrag Vlajnic, Lothar Roessig, Burkert Pieske   +8 more
doaj   +1 more source

The year in cardiology: heart failure 2014 [PDF]

, 2017
The year 2014 has become a remarkable year for heart failure. A bad start was caused by the publication of TOPCAT, showing that spironolactone did not prove to be beneficial for the treatment of patients with heart failure and preserved ejection fraction
Ruschitzka, Frank, Voors, Adriaan A.
core  

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction [PDF]

, 2018
Background: Information on the pathophysiological differences between heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF) is needed Objectives: The purpose of this study was to establish ...
Anker, Stefan D., Cleland, John G. F., Dickstein, Kenneth, Filippatos, Gerasimos S., Hillege, Hans L., Lang, Chim, Metra, Marco, Ng, Leong Loke, Ouwerkerk, Wouter, Ponikowski, Piotr, Samani, Nilesh J., Tromp, Jasper, van der Harst, Pim, van der Meer, Peter, van Veldhuisen, Dirk Jan, Voors, Adriaan A., Westenbrink, Daan, Zannad, Faiez, Zwinderman, Aelko H.   +18 more
core   +3 more sources

Microvascular Disease with Heart Failure with Reduced and Preserved Ejection Fraction in Patients with Type 2 Diabetes [PDF]

, 2020
Aims: Identification of patients with type 2 diabetes (T2D) at increased risk of incident heart failure (HF) beyond traditional risk factors such as prior myocardial infarction (MI) might allow selection of patients who would benefit from preventative ...
Doney, Alexander, Lang, Chim, McCrimmon, Rory, Mordi, Ify, Palmer, Colin, Tee, Aaron   +5 more
core   +2 more sources

Echocardiographic characterization of heart failure [PDF]

, 2021
Heart failure is a highly prevalent disease. In failure, the pump function of the heart is insufficient, leading to symptoms such as shortness of breath and fluid retention. Echocardiography is commonly used to diagnose heart failure.
Nauta, Jan F
core   +1 more source

Dietary nitrate and nitrite protect against doxorubicin‐induced cardiac fibrosis and oxidative protein damage in tumor‐bearing mice

FEBS Open Bio, EarlyView.
Chemotherapies such as doxorubicin can have toxic effects on healthy cardiovascular/heart tissue. Following up on a doxorubicin toxicity study in mice without tumors where nitrate water was cardioprotective (lessened toxicity), this study with tumor‐bearing mice undergoing doxorubicin treatment showed no negative effect of nitrate and nitrite on drug ...
Rama D. Yammani, Xiaofei Chen, Nildris Cruz‐Diaz, Xuewei Zhu, Swati Basu, Daniel B. Kim‐Shapiro, David R. Soto‐Pantoja, Leslie B. Poole   +7 more
wiley   +1 more source

Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy. [PDF]

, 2016
BackgroundEstrogen pretreatment has been shown to attenuate the development of heart hypertrophy, but it is not known whether estrogen could also rescue heart failure (HF).
Bopassa, Jean C, Centala, Alexander, Eghbali, Mansoureh, Iorga, Andrea, Li, Jingyuan, Nadadur, Rangarajan D, Ren, Shuxun, Saito, Tomoaki, Sharma, Salil, Stefani, Enrico, Toro, Ligia, Umar, Soban, Wang, Yibin   +12 more
core   +1 more source